This inventor holds 3 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Medimmune Limited. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- London, GB (2012)
- Loughborough, GB (2012 - 2015)
Company Filing History:
Years Active: 2012-2015
Title: The Innovations of Philip Mallinder
Introduction
Philip Mallinder is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of medical treatment through his innovative patents. With a total of three patents to his name, Mallinder's work focuses on binding members that target interleukin-6 (IL-6), a crucial component in inflammatory diseases and tumors.
Latest Patents
Mallinder's latest patents include compounds that consist of binding members, such as human antibody molecules, which specifically bind to interleukin-6 (IL-6) and neutralize its biological effects. These binding members are utilized in medical treatments aimed at addressing inflammatory diseases and tumors associated with IL-6. His work in this area has the potential to significantly impact therapeutic approaches for various health conditions.
Career Highlights
Throughout his career, Philip Mallinder has worked with prominent companies in the pharmaceutical industry, including Medimmune Limited and AstraZeneca. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Mallinder has collaborated with notable professionals in his field, including Steven Godfrey Lane and Simon Charles Cruwys. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Philip Mallinder's contributions to the field of medical treatment through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work on binding members for interleukin-6 has the potential to transform treatment options for inflammatory diseases and tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
